The SF3B1 gene is one of the most frequently mutated genes in CLL, reported to be mutated in 5-15% of early-stage patients with an increasing frequency in relapsed and refractory patients (16-28%) (18, 29, 30, 34, 39–42). This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.